[1]
|
(2009) Influenza statistics. Roche.
|
[2]
|
(2009) WHO confirmed human cases of avian influenza a (H5N1). World Health Organization Department Co- mmunicable Disease Surveillance and Response.
|
[3]
|
Tewari, D., Zellers, C., Acland, H. and Pedersen, J.C. (2007) Automated extraction of avian influenza virus for rapid detection using real-time RT-PCR. Journal of Clinical Virology, 40, 142-145.
|
[4]
|
Lee, W.-M., Grindle, K., Pappas, T., Marshall, D.J., Moser, M.J., Beaty, E.L., Shult, P.A., Prudent, J.R. and Gern, J.E. (2007) High-throughput, sensitive, and accu-rate multiplex PCR-microsphere flow cytometry system for large-scale comprehensive detection of respiratory viruses. Journal of Clinical Microbiology, 45, 2626-2634.
|
[5]
|
Nemoto, H., Komoriya, T. and Kohno, H. (2007) Devel-opment of latex turbidimetric immunoassay for rapid and sensitive detection of influenza virus. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi., 18, 117-126.
|
[6]
|
Severson, W. E., McDowell, M., Ananthan, S., Chung, D.H., Rasmussen, L., Sosa, M.I., White, E.L., Noah, J. and Jonsson, C.B. (10-1-2008) High-throughput screen-ing of a 100,000-compound library for inhibitors of in-fluenza a virus (H3N2). Journal of Biomolecular Screening, 13, 879-887.
|
[7]
|
Wang, S.Y., Su, C.Y., Lin, M., Huang, S.Y., Huang, W. I., Wang, C.C., Wu, Y.T., Cheng, T. J., Yu, H.M., Ren, C.T., Wu, C.Y., Wong, C.H. and Cheng, Y.S. (2-11-2009) HA-pseudotyped retroviral vectors for influenza an- tagonist screening. Journal of Biomolecular Screening, 1087-0571, 0833-0786.
|
[8]
|
Kapteyn, J.C., Porre, A.M., de Rond, E.J.P., Hessels, W.B., Tijms, M.A., Kessen, H., Slotboom, A.M.E., Oerlemans, M.A., Smit, D., van der Linden, J., Schoen, P. and Thus, J.L.G. (2-25-2009) HPLC-based quantification of haema- gglutinin in the production of egg- and MDCK cell- de-rived influenza virus seasonal and pandemic vaccines. Vaccine, 27, 1468-1477.
|
[9]
|
Wagaman, P.C., Leong, M.A. and Simmen, K.A. (2002) Development of a novel influenza a antiviral assay. Journal of Virological Methods, 105, 105-114.
|
[10]
|
Mo, C., Yamagata, R., Pan, A., Reddy, J., Hazari, N. and Duke, G. (2008) Development of a high-throughput Ala-mar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype. Journal of Virological Methods, 150, 63-69.
|
[11]
|
Aguero, M., San Miguel, E., Sanchez, A., Gomez-Tejedor, C. and Jimenez-Clavero, M. (2007) A fully automated procedure for the high-throughput detection of avian in-fluenza virus by real-time reverse transcriptionpoly-merase chain reaction. Avian Diseases, 51, 235-241.
|
[12]
|
Maroto, M., Fernandez, Y., Ortin, J., Pelaez, F. and Ca-bello, M.A. (8-1-2008) Development of an HTS assay for the search of anti-influenza agents targeting the interac-tion of viral RNA with the NS1 protein. Journal of Bio-molecular Screening, 13, 581-590.
|
[13]
|
Noah, J.W., Severson, W.D., Noah, L., Rasmussen, L., White, E.L. and Jonsson, C.B. (2007) A cell-based lumi-nescence assay is effective for high-throughput screening of potential influenza antivirals. Antiviral Research, 73, 50-59.
|
[14]
|
Cox, N., Webster, R. and Stohr, K. (2002) WHO manual on animal influenza diagnosis and surveillance. World Health Organization Department Communicable Disease Surveillance and Response.
|
[15]
|
Hamilton, M.A., Russo, R.C. and Thurston, R.V. (1977) Trimmed spearman-karber method for estimated median lethal concentration in toxicity bioassays. Environmental Science & Technology, 11, 714-719.
|
[16]
|
(2007) Food and Agriculture Organization of the United Nations (FAO) and World Organization for Animal Health (OIE). The Global Strategy for Prevention and Control of H5N1 Highly Pathogenic Avian Influenza1-39.
|
[17]
|
(2009) Financial impact of the Flu, http://www. flu-facts.com/impact/financial.aspx.
|